1 min read

Chemical Science Scotland
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio

Research Triangle Park, N.C., USA, 13th August 2019 / AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression. Synpromics will operate as a wholly owned subsidiary and remain headquartered in Edinburgh, United Kingdom.

Click here to read more.

For more information please follow links below.




End Point News

Wral Tech Wire

The Times